7th April 2020 This is a different alert to that issued on 04 March 2020 for Emerade 150 microgram auto-injectors. The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received updated information from the company that

On the 23rd March 2020 the government announced that all restaurants, pubs and cafés would have to close as part of measures to combat the spread of the novel coronavirus. The government has temporarily relaxed planning rules for these food

The Anaphylaxis Campaign is deeply saddened to learn of the death of its Honorary President, Dr. William Frankland, who died today (2 April 2020) at the age of 108. Throughout his life, Dr. Frankland worked to improve the lives of

With concerns from the allergic community about the lack of availability of FreeFrom and alternative foods during the coronavirus pandemic, The Anaphylaxis Campaign would like to share the following statement from Nutricia Paediatric regarding the availability of specialist formula: For

The Anaphylaxis Campaign, the only UK wide charity operating solely for the growing numbers of people at risk from severe allergic reactions and anaphylaxis, has heard increasing concerns from the allergic community about the availability of FreeFrom and alternative foods

The Anaphylaxis Campaign would like to wish its Honorary President, Dr. William Frankland MBE, a very happy 108th birthday. Throughout his life, Dr. Frankland has worked to improve the lives of others and for more than 50 years, he has

We have been closely monitoring the developing COVID-19 outbreak and want to reassure you that we are making plans to ensure we can continue to operate as usual and provide our much-needed services and resources to anyone who needs them.

We are saddened to learn of the tragic death of Nicholas Kelly, aged 16, due to a suspected allergic reaction, and would like to offer our deepest sympathies to his family at this difficult time. We have very little detail

4th March 2020 The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received updated information from the company that makes Emerade pens about the defect previously reported by the MHRA. The defect means some pens may